Skin cancer has become one of the top ten cancers in Hong Kong with more than 600 new cases in a year. The incidence of both non-melanoma and melanoma skin cancers has been increasing rapidly over the past decades, with 2 to 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. According to Skin Cancer Foundation Statistics, one in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. There is a great demand on improving the accuracy for assessing suspicious skin cancers with the support of technologies.
In the current medical practice, most of the medical doctors are heavily relying on their visual judgment to assess the suspected skin lesions. Medical doctors are lacking an effective tool to assist their assessment, and to improve the clinical assessment accuracy before opting for biopsy, which is an invasive, time-consuming and costly procedure.
Our developed solution which, composes of the hardware bio-optics image capturing system bundled with the software skin lesion analyzer, could assist the medical doctors to better identify and monitor the symptoms of potential skin cancer at higher accuracy, therefore fulfill the mentioned demands in the medical professional market.
The hardware system supports a dual mode operation, allowing the 10 times magnified skin lesion image as well as the normal type of images acquisition processes. In addition to the analysis of collected image data based on ABCD rules, the software skin lesion analyzer could facilitate semi-automated personal data management as well as provide skin lesion symptoms together with the analysis results to the medical doctors for long term monitoring purpose.
The designed & developed system has been granted for patent, and a small batch of functional prototypes has been produced with the in-house 3D printing technology and facilities.
COPYRIGHT© Hong Kong Productivity Council